GRAMD1B and immune system disorder: In Brazil, LAMB is indicated for patients aged < 1 year and > 50 years, severe illness based on severity score, renal, hepatic or cardiac insufficiency, HIV-coinfected patients, or other conditions leading to immunodeficiency, therapeutic failure to MA or other contraindications of use of MA [14, 37, 38].